Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Haifu Medical Technology is a global leader in non-invasive high-intensity focused ultrasound therapy. Its CE-marked HIFU devices are used for the ablation of both benign and malignant solid tumors. The company’s products are installed in over 30 countries with clinical use at major university hospitals worldwide. Clinical results demonstrate effective non-invasive treatment of uterine fibroids, adenomyosis, liver and pancreatic cancers with reduced patient harm compared to traditional surgery[2][7].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Haifu Medical Technology.